APOE and dementia: Literature on vitamin D and homocysteine in relation to the APOE genotype is limited, but a pattern similar to that of n‐3 PUFAs has been demonstrated for other preventive strategies to lower dementia risk, with APOE ε4 carriers benefitting more in preclinical stages.34